Motor response to amphetamine treatment, task-specific training, and limited motor experience in a postacute animal stroke model

Allen W Brown, Börje Bjelke, Kjell Fuxe

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Despite advances in acute treatment of ischemic cerebrovascular events, the most common clinical outcome is disabling neurological impairment. Despite experimental evidence that psychostimulant treatment can positively affect recovery rate after focal brain lesions, beyond rehabilitation therapies there are no currently accepted medical treatments indicated for diminishing neurological impairment after clinically established stroke. To test the effect of amphetamine, task-specific training, limiting motor experience, and their interaction on motor recovery in a postacute animal model of stroke, animals were nonaversively trained in beam walking before a unilateral photochemical sensorimotor cortex lesion and tested for 10 days after lesion. Animals were randomized to groups receiving: a single session of motor training 24 h after lesion; a single injection of amphetamine 2 mg/kg 24 h after lesion; beam-walking experience limited to testing on days 1 and 10 after lesion; and groups that received amphetamine treatment combined with training or combined with limited experience. Motor recovery was maximally enhanced by training, delayed by amphetamine treatment, and most negatively affected by limiting beam-walking experience during the recovery period. These findings support physical training after stroke, indicating that limiting physical activity negatively affects motor recovery and raises questions about the role of stimulant treatment to enhance motor recovery in the postacute phase after stroke.

Original languageEnglish (US)
Pages (from-to)102-108
Number of pages7
JournalExperimental Neurology
Volume190
Issue number1
DOIs
StatePublished - Nov 2004

Fingerprint

Amphetamine
Animal Models
Stroke
Walking
Therapeutics
Training Support
Rehabilitation
Injections
Brain

Keywords

  • Animal models
  • Cerebrovascular accident
  • Recovery of function
  • Rehabilitation

ASJC Scopus subject areas

  • Neurology
  • Neuroscience(all)

Cite this

Motor response to amphetamine treatment, task-specific training, and limited motor experience in a postacute animal stroke model. / Brown, Allen W; Bjelke, Börje; Fuxe, Kjell.

In: Experimental Neurology, Vol. 190, No. 1, 11.2004, p. 102-108.

Research output: Contribution to journalArticle

@article{dae74c85ac9f4e1a915d2b2a75119f12,
title = "Motor response to amphetamine treatment, task-specific training, and limited motor experience in a postacute animal stroke model",
abstract = "Despite advances in acute treatment of ischemic cerebrovascular events, the most common clinical outcome is disabling neurological impairment. Despite experimental evidence that psychostimulant treatment can positively affect recovery rate after focal brain lesions, beyond rehabilitation therapies there are no currently accepted medical treatments indicated for diminishing neurological impairment after clinically established stroke. To test the effect of amphetamine, task-specific training, limiting motor experience, and their interaction on motor recovery in a postacute animal model of stroke, animals were nonaversively trained in beam walking before a unilateral photochemical sensorimotor cortex lesion and tested for 10 days after lesion. Animals were randomized to groups receiving: a single session of motor training 24 h after lesion; a single injection of amphetamine 2 mg/kg 24 h after lesion; beam-walking experience limited to testing on days 1 and 10 after lesion; and groups that received amphetamine treatment combined with training or combined with limited experience. Motor recovery was maximally enhanced by training, delayed by amphetamine treatment, and most negatively affected by limiting beam-walking experience during the recovery period. These findings support physical training after stroke, indicating that limiting physical activity negatively affects motor recovery and raises questions about the role of stimulant treatment to enhance motor recovery in the postacute phase after stroke.",
keywords = "Animal models, Cerebrovascular accident, Recovery of function, Rehabilitation",
author = "Brown, {Allen W} and B{\"o}rje Bjelke and Kjell Fuxe",
year = "2004",
month = "11",
doi = "10.1016/j.expneurol.2004.07.005",
language = "English (US)",
volume = "190",
pages = "102--108",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Motor response to amphetamine treatment, task-specific training, and limited motor experience in a postacute animal stroke model

AU - Brown, Allen W

AU - Bjelke, Börje

AU - Fuxe, Kjell

PY - 2004/11

Y1 - 2004/11

N2 - Despite advances in acute treatment of ischemic cerebrovascular events, the most common clinical outcome is disabling neurological impairment. Despite experimental evidence that psychostimulant treatment can positively affect recovery rate after focal brain lesions, beyond rehabilitation therapies there are no currently accepted medical treatments indicated for diminishing neurological impairment after clinically established stroke. To test the effect of amphetamine, task-specific training, limiting motor experience, and their interaction on motor recovery in a postacute animal model of stroke, animals were nonaversively trained in beam walking before a unilateral photochemical sensorimotor cortex lesion and tested for 10 days after lesion. Animals were randomized to groups receiving: a single session of motor training 24 h after lesion; a single injection of amphetamine 2 mg/kg 24 h after lesion; beam-walking experience limited to testing on days 1 and 10 after lesion; and groups that received amphetamine treatment combined with training or combined with limited experience. Motor recovery was maximally enhanced by training, delayed by amphetamine treatment, and most negatively affected by limiting beam-walking experience during the recovery period. These findings support physical training after stroke, indicating that limiting physical activity negatively affects motor recovery and raises questions about the role of stimulant treatment to enhance motor recovery in the postacute phase after stroke.

AB - Despite advances in acute treatment of ischemic cerebrovascular events, the most common clinical outcome is disabling neurological impairment. Despite experimental evidence that psychostimulant treatment can positively affect recovery rate after focal brain lesions, beyond rehabilitation therapies there are no currently accepted medical treatments indicated for diminishing neurological impairment after clinically established stroke. To test the effect of amphetamine, task-specific training, limiting motor experience, and their interaction on motor recovery in a postacute animal model of stroke, animals were nonaversively trained in beam walking before a unilateral photochemical sensorimotor cortex lesion and tested for 10 days after lesion. Animals were randomized to groups receiving: a single session of motor training 24 h after lesion; a single injection of amphetamine 2 mg/kg 24 h after lesion; beam-walking experience limited to testing on days 1 and 10 after lesion; and groups that received amphetamine treatment combined with training or combined with limited experience. Motor recovery was maximally enhanced by training, delayed by amphetamine treatment, and most negatively affected by limiting beam-walking experience during the recovery period. These findings support physical training after stroke, indicating that limiting physical activity negatively affects motor recovery and raises questions about the role of stimulant treatment to enhance motor recovery in the postacute phase after stroke.

KW - Animal models

KW - Cerebrovascular accident

KW - Recovery of function

KW - Rehabilitation

UR - http://www.scopus.com/inward/record.url?scp=5044223028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5044223028&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2004.07.005

DO - 10.1016/j.expneurol.2004.07.005

M3 - Article

C2 - 15473984

AN - SCOPUS:5044223028

VL - 190

SP - 102

EP - 108

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 1

ER -